Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

It is used for the management of chronic COPD and it can be used as a rescue inhaler as well. It is available as a 45 mcg aerosol or a nebulizer (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL, or 1.25 ...

and dry powder inhalers used by more patients aged 40 to 60 years. Patients with asthma and chronic obstructive pulmonary disease (COPD) routinely switch from pressurized metered-dose inhalers (pMDIs) ...

Inhaler preference appeared to vary by age, with pDMI used by more patients aged 75 years and older, and DPI used by more patients aged 40 to 60 years. Patients with asthma and chronic obstructive ...

Better instruction on inhaler technique, and regular reminders, will have an impact on COPD and asthma admission figures, which are so costly for individual patients and the health system.

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Dry-powder corticosteroid inhalers, or those designed to have a low impact on climate, are as effective as those based on pressurized, metered doses at reducing the risk of poor outcomes in people ...

When you use an inhaler, you inhale the medication through a mouthpiece. With a nebulizer, you breathe in the medication via a mask that fits over your mouth and nose. These devices are essential for ...

Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...

“We’re trying to treat conditions like asthma and COPD with these inhalers, and we’re actually making it harder to breathe,” said Jyothi Tirumalasetty, a clinical assistant professor at ...